Trial Profile
A study evaluating effecacy of Everolimus-Eluting Stent in patients with Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Arterial occlusive disorders; Chronic limb-threatening ischemia; Ischaemia
- Focus Therapeutic Use
- 01 Apr 2017 New trial record